Worldwide Healthcare Trust PLC - Director/PDMR Shareholding

News provided by

Worldwide Healthcare Trust PLC

20 Jan, 2026, 16:42 GMT

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Timothy James Livett

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Worldwide Healthcare Trust PLC

b)

 

LEI

 

 

5493003YBCY4W1IMJU04

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 2.5p shares

 

 

GB00BN455J50

b)

 

Nature of the transaction

 

 

Dividend reinvestment

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

388.698 pence per share

 

39

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

39 ordinary 2.5p shares

 

 

388.698   pence per share

 

e)

 

Date of the transaction

 

 

9 January 2026

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

Name of authorised official of issuer responsible for making notification:

 

Mark Pope, for and on behalf of Frostrow Capital LLP

Company Secretary to WORLDWIDE HEALTHCARE TRUST PLC

 

 

 

The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.